THC, the active ingredient in marijuana, causes brain cancer cells to undergo a process called autophagy in which cells feed upon themselves, according to a study conducted by Guillermo Velasco and colleagues at Complutense University in Spain. Using mice designed to carry human brain cancer tumors, the researchers found that the growth of the tumors shrank when the animals received THC.

The study also involved two patients with glioblastoma multiforme, a highly aggressive form of brain cancer. Both patients had been enrolled in a clinical trial designed to test THC’s potential as a cancer therapy.

The researchers used electron microscopes to analyze brain tissue taken before and after a 26- to 30-day THC treatment regimen. They found that THC eliminated the cancer cells while leaving healthy cells intact.

News Release

Tweet

• View Comments

In a world-first breakthrough, UNSW medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease.

Tweet

• View Comments

Cancer comes in many forms, and nearly all are treatable when caught in time. The problem is, most people who have cancer don’t seek medical attention early enough to get the help they need.

An affordable and easy-to-use new kit can screen for lung, prostate, colon, and up to seven other types of cancer—and it may soon be available over-the-counter at your local pharmacy.

Hopefully this will help separate a cancer diagnosis from a death sentence.

Tweet

• View Comments

A simple 45-minute operation being developed by British scientists could cure blindness in millions of people around the world.

The revolutionary procedures could take place in six years and could be as commonplace as cataract surgery in less than a decade.

The new treatment centers on human embryonic stem cells grown in a laboratory.

Tweet

• View Comments

A drop of blood or speck of tissue no bigger than a full stop could soon be all that is required to diagnose cancers and assess their response to treatment, research suggests.

New technology that allows cancer proteins to be analysed in tiny samples could spell the end of surgical biopsies, which involve removing lumps of tissue, often under general anaesthetic.

Researchers at Stanford University, California, have developed a machine that separates cancer-associated proteins by means of their electric charge, which varies according to modifications on the protein’s surface.

One speck of blood or tissue may be enough to diagnose cancer

Tweet

• View Comments